Pioneering Advances in Bladder Cancer: New Drug Classes, Biomarkers, and Treatment Models

4 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
A virtual roundtable, hosted by Dr. Petros Grivas of Fred Hutchinson Cancer Center, contextualized the latest bladder cancer research updates and trials of relevancy to come out of the 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium. Dr. Grivas was joined by Drs. Guru Sonpavde, Elizabeth Plimack, Christopher Wallis, Terence Friedlander, and Matthew Galsky.

In the final segment of the roundtable, the panel elaborates on what excites them most about the future of bladder cancer research, highlighting promising advancements, including personalized mRNA vaccines, novel radioligand therapies, T-cell engagers, biomarker-driven treatment strategies, and a shift toward individualized care paradigms, reflecting a rapidly evolving field focused on improving patient outcomes.
Category
Oncology
Be the first to comment

Up Next